These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9818632)

  • 1. A large open-label study of venlafaxine in depressed outpatients by community-based physicians.
    Joffe RT; Marshall AM; Lee DK
    J Clin Psychiatry; 1998 Oct; 59(10):515-20. PubMed ID: 9818632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
    Thase ME
    J Clin Psychiatry; 1997 Sep; 58(9):393-8. PubMed ID: 9378690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
    Ballús C; Quiros G; De Flores T; de la Torre J; Palao D; Rojo L; Gutiérrez M; Casais L; Riesgo Y
    Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venlafaxine in the treatment of dysthymia: an open-label study.
    Hellerstein DJ; Batchelder ST; Little SA; Fedak MJ; Kreditor D; Rosenthal J
    J Clin Psychiatry; 1999 Dec; 60(12):845-9. PubMed ID: 10665631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
    Rudolph RL; Fabre LF; Feighner JP; Rickels K; Entsuah R; Derivan AT
    J Clin Psychiatry; 1998 Mar; 59(3):116-22. PubMed ID: 9541154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label evaluation of venlafaxine sustained release in outpatients with generalized anxiety disorder with comorbid major depression or dysthymia: effectiveness, tolerability and predictors of response.
    Perugi G; Frare F; Toni C; Ruffolo G; Torti C
    Neuropsychobiology; 2002; 46(3):145-9. PubMed ID: 12422062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venlafaxine in treatment-resistant major depression: a Canadian multicenter, open-label trial.
    de Montigny C; Silverstone PH; Debonnel G; Blier P; Bakish D
    J Clin Psychopharmacol; 1999 Oct; 19(5):401-6. PubMed ID: 10505581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
    Costa e Silva J
    J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, open-label comparison of venlafaxine and fluoxetine in depressed outpatients.
    Diaz-Martinez A; Benassinni O; Ontiveros A; Gonzalez S; Salin R; Basquedano G; Martinez RA
    Clin Ther; 1998; 20(3):467-76. PubMed ID: 9663362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine in dysthymic disorder.
    Dunner DL; Hendrickson HE; Bea C; Budech CB
    J Clin Psychiatry; 1997 Dec; 58(12):528-31. PubMed ID: 9448655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
    Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
    J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium augmentation of venlafaxine: an open-label trial.
    Hoencamp E; Haffmans J; Dijken WA; Huijbrechts IP
    J Clin Psychopharmacol; 2000 Oct; 20(5):538-43. PubMed ID: 11001238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of venlafaxine and amitriptyline in outpatients with major depression with or without melancholia.
    Gentil V; Kerr-Correa F; Moreno R; D'Arrigo Busnello E; De Campos JA; Juruena MF; Lafer B; Moreno DH; De Cassia Rodrigues RL; Tiosso A; Benedictis E
    J Psychopharmacol; 2000 Mar; 14(1):61-6. PubMed ID: 10757255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of venlafaxine in the treatment of primary dysthymia.
    Ravindran AV; Charbonneau Y; Zaharia MD; al-Zaid K; Wiens A; Anisman H
    J Psychiatry Neurosci; 1998 Nov; 23(5):288-92. PubMed ID: 9846033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia.
    Tzanakaki M; Guazzelli M; Nimatoudis I; Zissis NP; Smeraldi E; Rizzo F
    Int Clin Psychopharmacol; 2000 Jan; 15(1):29-34. PubMed ID: 10836283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group.
    Silverstone PH; Ravindran A
    J Clin Psychiatry; 1999 Jan; 60(1):22-8. PubMed ID: 10074873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venlafaxine treatment of binge-eating disorder associated with obesity: a series of 35 patients.
    Malhotra S; King KH; Welge JA; Brusman-Lovins L; McElroy SL
    J Clin Psychiatry; 2002 Sep; 63(9):802-6. PubMed ID: 12363121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine compared with fluoxetine in outpatients with depression and concomitant anxiety.
    De Nayer A; Geerts S; Ruelens L; Schittecatte M; De Bleeker E; Van Eeckhoutte I; Evrard JL; Linkowski P; Fossion P; Leyman S; Mignon A
    Int J Neuropsychopharmacol; 2002 Jun; 5(2):115-20. PubMed ID: 12135535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.